Literature DB >> 25950286

Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments.

Elham Hatef1, Dayse F Sena, Katherine A Fallano, Jonathan Crews, Diana V Do.   

Abstract

BACKGROUND: Rhegmatogenous retinal detachment (RRD) is a full-thickness break in the sensory retina, caused by vitreous traction on the retina. While pneumatic retinopexy, scleral buckle, and vitrectomy are the accepted surgical interventions for eyes with RRD, their relative effectiveness has remained controversial.
OBJECTIVES: The objectives of this review were to assess the effectiveness and safety of pneumatic retinopexy versus scleral buckle or pneumatic retinopexy versus a combination treatment of scleral buckle and vitrectomy for people with RRD. The secondary objectives were to summarize any data on economic measures and quality of life. SEARCH
METHODS: We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (2014, Issue 12), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to January 2015), EMBASE (January 1980 to January 2015), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to January 2015), the ISRCTN registry (www.isrctn.com/editAdvancedSearch), ClinicalTrials.gov (www.clinicaltrials.gov) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 13 January 2015. SELECTION CRITERIA: We included all randomized or quasi-randomized controlled trials comparing the effectiveness of pneumatic retinopexy versus scleral buckle (with or without vitrectomy) for eyes with RRD. DATA COLLECTION AND ANALYSIS: After screening for eligibility, two review authors independently extracted study characteristics, methods, and outcomes. We followed systematic review standards as set forth by The Cochrane Collaboration. MAIN
RESULTS: We included two randomized controlled trials (218 eyes of 216 participants) comparing the effectiveness of pneumatic retinopexy versus scleral buckle for eyes with RRD. We identified no studies investigating the comparison of pneumatic retinopexy versus a combination treatment of scleral buckle and vitrectomy. Of the two included studies, one was a small study with 20 participants enrolled in Ireland and followed for an average of 16 months. The second study was larger with 196 participants (198 eyes) enrolled in the United States and followed for at least 6 months. Cautious interpretation of the results is warranted, since we graded the evidence as low to moderate quality due to insufficient reporting of study methods and imprecision and inconsistency among study results.Both studies showed fewer eyes achieving retinal reattachment in the pneumatic retinopexy group compared with the scleral buckle group by six-months follow-up (risk ratio (RR) 0.89, 95% confidence interval (CI) 0.77 to 1.02, 218 eyes); however, we are uncertain as to whether the intervention has an important effect on reattachment because the results are imprecise. Eyes in the pneumatic retinopexy group also were more likely to have had a recurrence of retinal detachment by six-months follow-up (RR 1.80, 95% CI 1.00 to 3.24, 218 eyes); however, we are uncertain as to whether the intervention has an important effect on recurrence because the lower CI equals no difference. Neither study reported mean change in visual acuity, quality of life data, or economic measures. Differences between the pneumatic retinopexy group and scleral buckle group were uncertain due to small numbers of events with respect to operative ocular adverse events (RR 0.67, 95% CI 0.32 to 1.42, 218 eyes), development of cataract (RR 0.92, 95% CI 0.06 to 14.54, 198 eyes), glaucoma (RR 0.31, 95% CI 0.03 to 2.91, 198 eyes), macular pucker (RR 0.74, 95% CI 0.20 to 2.67, 198 eyes), and proliferative vitreoretinopathy (RR 0.94, 95% CI 0.30 to 2.96, 218 eyes). Fewer eyes in the pneumatic retinopexy group compared with the scleral buckle group experienced choroidal detachment (RR 0.17, 95% CI 0.05 to 0.57, 198 eyes) or myopic shift equal to or greater than 1 diopter spherical equivalent (RR 0.04, 95% CI 0.01 to 0.13, 198 eyes). AUTHORS'
CONCLUSIONS: The evidence suggests that pneumatic retinopexy may result in lower rates of reattachment and higher rates of recurrence than scleral buckle for eyes with RRD, but does not rule out no difference between procedures. The relative safety of the procedures is uncertain and the relative effects of these procedures in terms of other patient-important outcomes, such as visual acuity and quality of life, is unknown. Due to the limited information available between pneumatic retinopexy and scleral buckle procedures, future research addressing these evidence gaps are warranted.

Entities:  

Mesh:

Year:  2015        PMID: 25950286      PMCID: PMC4451439          DOI: 10.1002/14651858.CD008350.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  23 in total

Review 1.  Visual recovery after retinal detachment.

Authors:  W H Ross; F A Stockl
Journal:  Curr Opin Ophthalmol       Date:  2000-06       Impact factor: 3.761

2.  Scleral buckling technique without retinopexy for treatment of rhegmatogeneous: a pilot study.

Authors:  Marta S Figueroa; Michelle Della Corte; Sandro Sbordone; Antonio Romano; Maria T Alvarez; Símon J Villalba; Alessandro Schirru
Journal:  Retina       Date:  2002-06       Impact factor: 4.256

3.  Pneumatic retinopexy. A two-year follow-up study of the multicenter clinical trial comparing pneumatic retinopexy with scleral buckling.

Authors:  P E Tornambe; G F Hilton; D A Brinton; T P Flood; S Green; W S Grizzard; M E Hammer; S R Leff; L Masciulli; C M Morgan
Journal:  Ophthalmology       Date:  1991-07       Impact factor: 12.079

4.  Effect of topical aqueous suppression on intraocular gas duration after pure perfluoropropane injection in nonvitrectomized eyes with retinal detachment.

Authors:  Jason Hsu; Adam T Gerstenblith; Nikolas J S London; Sunir J Garg; Marc J Spirn; Joseph I Maguire; Carl Park; Arunan Sivalingam
Journal:  Retina       Date:  2014-12       Impact factor: 4.256

5.  [Comparison between 2 methods of treatment of retinal detachment. (Advantages of H.A. Lincoff's method].

Authors:  M Massin; A Dubois-Poulsen; F Damois
Journal:  Arch Ophtalmol Rev Gen Ophtalmol       Date:  1971-11

6.  Primary rhegmatogenous retinal detachment: 20 years of change.

Authors:  M Minihan; V Tanner; T H Williamson
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

7.  Pneumatic retinopexy versus scleral buckling: a randomised controlled trial.

Authors:  A Mulvihill; T Fulcher; V Datta; R Acheson
Journal:  Ir J Med Sci       Date:  1996 Oct-Dec       Impact factor: 1.568

8.  The Swedish Retinal Detachment Register. I. A database for epidemiological and clinical studies.

Authors:  P V Algvere; P Jahnberg; O Textorius
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-02       Impact factor: 3.117

9.  What happens to untreated asymptomatic retinal breaks, and are they affected by posterior vitreous detachment?

Authors:  N E Byer
Journal:  Ophthalmology       Date:  1998-06       Impact factor: 12.079

Review 10.  Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments.

Authors:  Elham Hatef; Dayse F Sena; Katherine A Fallano; Jonathan Crews; Diana V Do
Journal:  Cochrane Database Syst Rev       Date:  2015-05-07
View more
  14 in total

Review 1.  Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments.

Authors:  Dayse F Sena; Raphael Kilian; Su-Hsun Liu; Stanislao Rizzo; Gianni Virgili
Journal:  Cochrane Database Syst Rev       Date:  2021-11-11

Review 2.  Complications in Retinal Surgery: A Review of Corneal Changes Following Vitreoretinal Procedures.

Authors:  Paula A Sepulveda-Beltran; Harry Levine; Victoria S Chang; Allister Gibbons; Jaime D Martinez
Journal:  Int Ophthalmol Clin       Date:  2022-06-22

3.  Evaluation of macular vessel density changes after vitrectomy with silicone oil tamponade in patients with rhegmatogenous retinal detachment.

Authors:  Jian Jiang; Song Chen; Ya-Ding Jia; Rui Li; Jin-Xiu Zhou; Rui-Mei Li
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

Review 4.  Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment.

Authors:  Charles P Wilkinson
Journal:  Cochrane Database Syst Rev       Date:  2014-09-05

Review 5.  Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments.

Authors:  Elham Hatef; Dayse F Sena; Katherine A Fallano; Jonathan Crews; Diana V Do
Journal:  Cochrane Database Syst Rev       Date:  2015-05-07

6.  Theoretical Assessment of the Risk of Ocular Hypotony in Patients With Intravitreal Gas Bubbles Who Travel Through Subsea Tunnels.

Authors:  Neda Rashidi; Vineet S Thomas; Rouzbeh Amini
Journal:  Transl Vis Sci Technol       Date:  2018-01-03       Impact factor: 3.283

7.  Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments.

Authors:  Ljubo Znaor; Aleksej Medic; Susanne Binder; Ana Vucinovic; Josipa Marin Lovric; Livia Puljak
Journal:  Cochrane Database Syst Rev       Date:  2019-03-08

Review 8.  A Review of Innovations in Rhegmatogenous Retinal Detachment Surgical Techniques.

Authors:  Achia Nemet; Ala Moshiri; Glenn Yiu; Anat Loewenstein; Elad Moisseiev
Journal:  J Ophthalmol       Date:  2017-05-07       Impact factor: 1.909

9.  Clinical Outcomes of Rhegmatogenous Retinal Detachment Treated With Pneumatic Retinopexy.

Authors:  Nicolas A Yannuzzi; Charles Li; Danielle Fujino; Scott P Kelly; Flora Lum; Harry W Flynn; D Wilkin Parke
Journal:  JAMA Ophthalmol       Date:  2021-06-17       Impact factor: 8.253

10.  Pneumatic retinopexy: A cost-effective alternative.

Authors:  Ritesh Narula
Journal:  Indian J Ophthalmol       Date:  2018-03       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.